Provided by Tiger Fintech (Singapore) Pte. Ltd.

Moderna, Inc.

24.25
-0.1300-0.53%
Post-market: 24.370.1200+0.49%19:59 EDT
Volume:7.13M
Turnover:176.19M
Market Cap:9.38B
PE:-2.78
High:25.32
Open:24.68
Low:24.22
Close:24.38
Loading ...

Moderna Inc. Stock Slips 8.9%, Underperforms Competitors

Dow Jones
·
01 Apr

Moderna (MRNA) Stock Trades Down, Here Is Why

StockStory
·
01 Apr

BUZZ - S&P 500 top and bottom performing stocks at about 03:30 p.m. EDT

Reuters
·
01 Apr

Moderna, Novavax, Other Vaccine Makers Retreat Following Resignation of FDA's Vaccines Chief

MT Newswires Live
·
01 Apr

Moderna and Novavax shares plunge after key FDA official steps down, citing discord with RFK Jr. who he says ‘wishes subservient confirmation of his misinformation and lies’

Fortune
·
01 Apr

Moderna put volume heavy and directionally bearish

TIPRANKS
·
31 Mar

Vaccine Stocks Fall After Ousting of FDA's Vaccine Head

Dow Jones
·
31 Mar

Pharma Stocks Sink After Ouster of Top FDA Vaccine Regulator

Reuters
·
31 Mar

Fiery Resignation of Top FDA Official Sparks Biotech Selloff -- Barrons.com

Dow Jones
·
31 Mar

Moderna's RSV Vaccine Receives Approval in Australia

MT Newswires Live
·
31 Mar

BUZZ-Vaccine makers fall on reports top FDA vaccine official to resign

Reuters
·
31 Mar

Pre-Bell|U.S. Futures Tumble; Nvidia Drops 4%; Tesla Sinks 6%; Moderna Plunges 14%; Mr. Cooper Surges 26%

Tiger Newspress
·
31 Mar

BUZZ-U.S. STOCKS ON THE MOVE-Gene therapy cos, gold miners, chipmakers

Reuters
·
31 Mar

Moderna Shares Extend Premarket Losses, Last Down 12.7%

THOMSON REUTERS
·
31 Mar

S&P 500 Futures Fall In Premarket Trading; Vaxcyte, Moderna Lag

Dow Jones
·
31 Mar

BUZZ-Moderna falls on reports FDA official Peter Marks resigns

Reuters
·
31 Mar

Moderna Shares Down 7.6% Premarket After Report Top Vaccine Official Peter Marks Forced Out at FDA

THOMSON REUTERS
·
31 Mar

Moderna Receives Australian Therapeutic Goods Administration Approval for Rsv Vaccine for Older Adults

THOMSON REUTERS
·
31 Mar

Jim Cramer Slams Moderna, Inc. (MRNA) as One of the Year’s Biggest Disappointments

Insider Monkey
·
30 Mar

Jim Cramer: Moderna (MRNA) Blew It – But Their Cash Pile Could Save Them!

Insider Monkey
·
28 Mar